Gyre Therapeutics Inc. (GYRE) — Net Asset Quality Index
Gyre Therapeutics Inc. (GYRE) has a Net Asset Quality Index of 84.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $162.01 Million minus total liabilities of $25.03 Million yields net assets of $136.99 Million. A higher index indicates a stronger, lower-leverage balance sheet. See GYRE defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Gyre Therapeutics Inc. Net Asset Quality Index Over Time (2002–2025)
This chart shows how Gyre Therapeutics Inc.'s Net Asset Quality Index has evolved across 24 annual periods from 2002 to 2025. As of March 2026, the index stands at 84.6%, representing net assets of $136.99 Million against total assets of $162.01 Million USD. Explore GYRE cash flow conversion to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Gyre Therapeutics Inc. (2002–2025)
The table below presents the year-by-year Net Asset Quality Index for Gyre Therapeutics Inc. from 2002 to 2025, covering 24 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see GYRE stock market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 85.6% | $142.28 Million | $166.13 Million | $23.85 Million | ▲ +7.2 pp |
| 2024 | 78.5% | $98.40 Million | $125.41 Million | $27.00 Million | ▲ +66.5 pp |
| 2023 | 12.0% | $13.95 Million | $116.54 Million | $102.59 Million | ▼ -73.2 pp |
| 2022 | 85.2% | $72.22 Million | $84.75 Million | $12.54 Million | ▲ +11.4 pp |
| 2021 | 73.8% | $41.09 Million | $55.66 Million | $14.57 Million | ▼ -6.4 pp |
| 2020 | 80.2% | $76.07 Million | $94.85 Million | $18.78 Million | ▲ +10.9 pp |
| 2019 | 69.3% | $68.34 Million | $98.55 Million | $30.22 Million | ▼ -26.7 pp |
| 2018 | 96.0% | $119.94 Million | $124.92 Million | $4.97 Million | ▲ +18.1 pp |
| 2017 | 77.9% | $30.77 Million | $39.51 Million | $8.74 Million | ▲ +35.7 pp |
| 2016 | 42.2% | $16.07 Million | $38.09 Million | $22.02 Million | ▼ -3.0 pp |
| 2015 | 45.2% | $31.43 Million | $69.52 Million | $38.10 Million | ▼ -52.2 pp |
| 2014 | 97.4% | $109.08 Million | $112.00 Million | $2.91 Million | ▲ +5.1 pp |
| 2013 | 92.3% | $134.61 Million | $145.87 Million | $11.26 Million | ▼ -0.5 pp |
| 2012 | 92.8% | $175.91 Million | $189.58 Million | $13.66 Million | ▲ +25.3 pp |
| 2011 | 67.5% | $174.29 Million | $258.13 Million | $83.84 Million | ▲ +32.6 pp |
| 2010 | 35.0% | $91.85 Million | $262.79 Million | $170.94 Million | ▲ +13.3 pp |
| 2009 | 21.6% | $68.99 Million | $319.38 Million | $250.39 Million | ▼ -36.6 pp |
| 2008 | 58.2% | $57.37 Million | $98.55 Million | $41.18 Million | ▲ +6.1 pp |
| 2007 | 52.1% | $51.58 Million | $98.96 Million | $47.38 Million | ▼ -27.8 pp |
| 2006 | 79.9% | $65.00 Million | $81.37 Million | $16.37 Million | ▲ +660.1 pp |
| 2005 | -580.3% | $-162.48 Million | $28.00 Million | $190.48 Million | ▼ -369.0 pp |
| 2004 | -211.3% | $-122.97 Million | $58.20 Million | $181.17 Million | ▼ -308.2 pp |
| 2003 | 96.9% | $45.93 Million | $47.39 Million | $1.46 Million | ▲ +0.8 pp |
| 2002 | 96.2% | $52.29 Million | $54.38 Million | $2.09 Million | — |